Geneva, March 23 -- International Clinical Trials Registry received information related to the study (ISRCTN79266681) titled 'A study of photodynamic therapy for long-lasting central serous chorioretinopathy' on March 5.
Study Type: Interventional
Study Design:
Allocation: Randomized controlled trial
Masking: Blinded (masking used)
Control: Placebo
Assignment: Parallel
Purpose: Treatment
Primary Sponsor: University of Bristol - Bristol Trials Centre
Condition:
Central Serous Chorioretinopathy (CSCR)
Eye Diseases
Intervention:
This is a multicentre, double masked, placebo controlled randomised trial comparing half dose photodynamic therapy (PDT) using verteporfin with placebo infusion plus laser in adults with chronic central sero...